Brief: Catalent Signs Agreement To Sell Somerset, NJ Oral Solids Facility
Oct 14 (Reuters) - Catalent Inc CTLT.N :
* CATALENT SIGNS AGREEMENT TO SELL SOMERSET, NJ ORAL SOLIDS
FACILITY
* CATALENT INC - FINANCIAL DETAILS OF AGREEMENT, WHICH IS
EXPECTED
TO CLOSE IN EARLY 2025, HAVE NOT BEEN DISCLOSED
Source text for Eikon: ID:nBwcdcwGla
Further company coverage: CTLT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled